Tetrazole derivatives and their use for the treatment of cardiovascular diseases

US8183271B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Stephan Bartel · Bensberg, DE
• Michael Hahn · Langenfeld, DE
• Wahed Ahmed Moradi · Monheim, DE
• Eva-Maria Becker · Wuppertal, DE
• Thomas Rölle · Leverkusen, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Frank Wunder · Wuppertal, DE
• Andreas Knorr · Erkrath, DE

Key dates

• Filing date: Oct 9, 2006
• Grant date: May 22, 2012
• Expiry date: Mar 17, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel tetrazole derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.